Clinical considerations for DPD deficiency testing in advanced cancer patients: tumor lysis syndrome should be considered as a major interference

MeSH terms

• Dihydropyrimidine Dehydrogenase Deficiency*
• Dihydrouracil Dehydrogenase (NADP)
• Fluorouracil
• Humans
• Neoplasms* / complications
• Neoplasms* / diagnosis
• Tumor Lysis Syndrome* / diagnosis
• Tumor Lysis Syndrome* / etiology